Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2010
10/06/2010EP2236517A1 Anti-fibronectin fragment monoclonal antibody
10/06/2010EP2236515A1 Component protein pa1698 for type-iii secretion system of pseudomonas aeruginosa
10/06/2010EP2236172A1 Combination therapy comprising anti-CD20 and anti-CD40 antibodies for the treatment of B cell-related cancers
10/06/2010EP2236156A2 Methods for treating and diagnosing Psoriasis
10/06/2010EP2236154A1 Immunoglobulin formulation and method of preparation thereof
10/06/2010EP2236152A1 Albumin fusion proteins
10/06/2010EP2235539A2 Use of a protein or nitrated peptide sequence for implementing a diagnosis method
10/06/2010EP2235189A1 Methods for inhibiting angiogenesis using egfl8 antagonists
10/06/2010EP2235064A1 Method for making antibody fc-heterodimeric molecules using electrostatic steering effects
10/06/2010EP2235063A1 Anti-hedgehog antibodies
10/06/2010EP2235062A1 Improved anti-trkb antibodies
10/06/2010EP2235061A1 Afucosylated antibodies against ccr5 and their use
10/06/2010EP2235059A1 Fc variants with altered binding to fcrn
10/06/2010EP2235058A2 Anti-amyloid antibodies and uses thereof
10/06/2010EP2235057A2 G immunoglobulin used against anthrax toxins
10/06/2010EP2235056A1 Crystallization of anti-cd20 antibodies
10/06/2010EP2235055A2 Ephrin type-a receptor 10 protein
10/06/2010EP2235052A1 Proteinaceous binding molecules comprising purification tags or inert variable domains
10/06/2010EP2235051A2 Glycosyltransferases, polynucleotides encoding these and methods of use
10/06/2010EP2235044A1 New polypeptides having affinity for her2
10/06/2010EP2234641A2 Monoclonal antibodies against cd32b
10/06/2010EP1736484B1 An gene engineering recombinant anti-cea, anti-cd3 and anti-cd28 single-chain tri-specific antibody
10/06/2010EP1594958B1 Activation and expansion of t cells
10/06/2010EP1513554B1 Cd16a binding proteins and use for the treatment of immune disorders
10/06/2010EP1451193B1 Podophyllotoxins as antiproliferative agents
10/06/2010EP1220906B1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby
10/06/2010EP0873363B1 High affinity human antibodies to tumor antigens
10/06/2010CN201598248U 用于筛选IgG与IgM类型抗体的分离板 IgG and IgM type for screening antibodies separator plate
10/06/2010CN1646684B Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
10/06/2010CN1522516B Secure header information for multi-content e-mail
10/06/2010CN101855553A Predictive markers for ovarian cancer
10/06/2010CN101855244A Novel antibodies
10/06/2010CN101855243A Method for the preparation of new oligoclonal antibodies
10/06/2010CN101855242A Rationally designed, synthetic antibody libraries and uses therefor
10/06/2010CN101855241A Monoclonal antibodies against ANGPTL3
10/06/2010CN101855217A Mycophenolic acid immunogens and antibodies
10/06/2010CN101854950A Donor specific antibody libraries
10/06/2010CN101854949A Methods and compositions for modulating t cells
10/06/2010CN101852807A Sorghum mosaic virus tri-anti sandwich enzyme-linked immuno sorbent assay kit
10/06/2010CN101852804A New applications of antibody of GDF15 (Growth differentiation factor 15) protein
10/06/2010CN101851292A Establishment of method for preparing melamine high-titer antibody by using melamine derivatives
10/06/2010CN101851291A Heavy chain and light chain variable regions of anti-human BAFF monoclonal antibody
10/06/2010CN101851290A Preparation and production technology of humanization NOGO-A resisting monoclonal antibody
10/06/2010CN101851289A Humanized antibody of H5 subtype avian influenza virus hemagglutinin and application thereof
10/06/2010CN101851286A Mammalian cytokine: interleukin-B30 and related reagents
10/06/2010CN101851279A Pseudomonas aeruginosa antigens
10/06/2010CN101334356B Gas sensors
10/06/2010CN101113163B Hla-a24-restricted cancer antigen peptides
10/05/2010US7807879 Stimulating root growth via introducing cytokinin oxidase protein sequences; point mutations
10/05/2010US7807877 Genetic sequences having methyltransferase activity and uses therefor
10/05/2010US7807863 Transgenic bovine having reduced prion protein activity and uses thereof
10/05/2010US7807862 Transgenic bovine comprising human growth hormone in its serum and methods of making
10/05/2010US7807810 Nucleic acids encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby
10/05/2010US7807805 isolated nucleic acid encoding an immunogenic peptide recognized by T lymphocytes; host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
10/05/2010US7807799 Preventing polypeptide loss during chromatographic purification via protease inhibitors, temperature and/or pH adjustments
10/05/2010US7807798 Epidermal growth factor receptor specific immunoglobulin for use in treatment of cell proliferative disorders; antitumor agents
10/05/2010US7807797 Human cytotoxic T-lymphocyte antigen 4 (CTLA-4); heavy and light chain sequences spanning the complementarity determining regions (CDRs), specifically from within FR1 and/or CDR1 through CDR3 and/or within FR4; administering an antibody or antigen-binding portion to treat a tumor
10/05/2010US7807796 ULBP antibodies
10/05/2010US7807795 Antibodies to osteoprotegerin binding proteins
10/05/2010US7807794 Anti-α2 integrin antibodies and their uses
10/05/2010US7807793 Antiallergenics; reducing eosinophil inflammation as antiproliferation agents of IL5 secreting cells and inhibiters of adherence mechanism
10/05/2010US7807792 Wilms tumor protein-1 (WT1) for use in treatment and prevention of celll proliferative disorders; antitumor agents
10/05/2010US7807791 Antibodies immunoreactive with mutant 5-enolpyruvlshikimate-3-phosphate synthase
10/05/2010US7807790 Peptide sequence that promotes tumor invasion
10/05/2010US7807789 Using heavy isotope labeled peptides as tools in quantifying and detecting tyrosine phosphorylated proteins in epidermal growth factor receptor signaling pathway
10/05/2010US7807788 Interlukin receptor specific immunoglobulin for use in treatment and prevention of severe asthma, atopic dermatitis, fibrotic and chronic obstructive pulmonary diseases
10/05/2010US7807786 Activation antigen expressed on B-cells for treating conditions associated with aberrant or increased T-cell proliferation
10/05/2010US7807780 Multi-component biological transport systems
10/05/2010US7807777 Marker peptide for alzheimer's disease
10/05/2010US7807636 Antiinflammatory ligand for use in prevention and treatment of intestinal ischemia, salmonellosis and/or sepsis; biodrug for reducing or preventing damage to tissue or organs caused by acute inflammatory response in a bovine; veterinary medicine
10/05/2010US7807463 Pretreatment of animal with antibodies to sensitize animal; controlling dosage
10/05/2010US7807441 Nucleotide sequences which code protein that induces cytotoxic T-lymphocyte immunity against weak selfproteins; antitumor agents
10/05/2010US7807416 Antibodies and methods for generating genetically altered antibodies with enhanced effector function
10/05/2010US7807412 Using platelete derived growth fator as tool in detection of modulators for prevention and treatment of cell proliferative disorders
10/05/2010US7807391 target substance capturing body comprising a substrate and a protein utilizing an anti-gold antibody and a gold-binding side which is a part of the anti-gold antibody; used for the detection of a target substance
10/05/2010US7807390 G-protein coupled receptor ligands and methods
10/05/2010US7807385 Method of detecting PRO9917
10/05/2010US7807380 antibodies that specifically bind to native proBNP; method of correlating the level of native proBNP to the diagnosis of heart failure, a kit for detection of native proBNP and to a hybridoma cell line producing an antibody to native proBNP; biomarkers
10/05/2010US7807371 Methods of selecting dopaminergic neuron proliferative progenitor cells using Lrp4/Corin markers
10/05/2010US7807167 using an agent that specifically binds to an alpha-4 integrin or a dimer comprising an alpha-4 integrin; treatment of multiple sclerosis or inflammatory disease of the gastrointestinal tract
10/05/2010US7807166 Stimulating remyelination of central nervous system axons by administering a monoclonal antibody characterized by their ability to bind structures and cells within the central nervous system, including oligodendrocytes; including neural dysfunction caused by spinal cord injury
10/05/2010US7807163 Antibodies against GPR64 and uses thereof
10/05/2010US7807161 Humanized anti-human osteopontin antibody
10/05/2010US7807160 monoclonal antibody, or antigen binding fragment thereof that binds to human IL-23p19 at an epitope comprising residues 133-140 of SEQ ID NO: 29; treatment of inflammatory, autoimmune, and proliferative disorders
10/05/2010US7807159 Antibodies to myostatin
10/05/2010US7807157 Monoclonal antibodies and use thereof
10/05/2010US7807155 IL-17 antagonistic antibodies
10/05/2010US7807154 Leptin antagonist and method for quantitative measurement of leptin
10/05/2010US7807153 Apo-2 receptor agonist antibodies
10/05/2010US7807136 Treatment of stomach cancer with steroid compounds and precipitation
10/05/2010US7807133 Diagnosis, therapy of tumors; as compared to avidin, the diavidins have shown ability to increase amount of labelled biotin on target, when used in an in vitro pretargeting test using supported human tenascin, the biotinylated anti-tenascin monoclonal antibody (Mab-B), avidin/diavidin, and biotin-3H
10/05/2010CA2298438C Synthetic antigen for the detection of antibodies immunoreactive with hiv virus
10/05/2010CA2086325C Ligand for cd28 receptor on b cells and methods
09/2010
09/30/2010WO2010111671A1 Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications
09/30/2010WO2010111633A2 Antibody composition with altered fab sialylation
09/30/2010WO2010111625A1 Compositions and methods for using multispecific-binding proteins comprising an antibody-receptor combination
09/30/2010WO2010111516A2 Compositions and methods for inhibiting biofilms
09/30/2010WO2010111378A1 Membrane evaporation for generating highly concentrated protein therapeutics
09/30/2010WO2010111367A1 Anti-fgfr3 antibodies and methods using same
09/30/2010WO2010111299A2 Synthetic antibodies
1 ... 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 ... 1494